BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Jiang YJ, Wu L, Yang X, Pu Y, Ning BJ, Peng N, Zhu XJ. Dermatitis bullosa caused by the immune checkpoint inhibitor camrelizumab: A case report. World J Clin Cases 2025; 13(8): 97677 [PMID: 40094109 DOI: 10.12998/wjcc.v13.i8.97677]
URL: https://www.wjgnet.com/2307-8960/full/v13/i8/97677.htm
(128) (129) (0) (0) (17) (3696) (1)
Number Citing Articles
1
Camrelizumab. Reactions Weekly 2026; 2129(1) doi: 10.1007/s40278-026-98259-6
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.